Neopharma

Neovault

The Next Generation Digital Drug &
Impairment Testing Solution

NEOVAULT® is the first device-agnostic worker psychosocial monitoring platform that integrates drug and alcohol testing with cognitive impairment screening — delivering a complete picture of workforce fitness for duty.
Using a smartphone or tablet app, NEOVAULT® captures and processes test results in real time, delivering instant platform reporting and the real-time visibility leaders need to manage risk, meet compliance obligations, and protect their workforce.

Neovault Dashboard and Mobile App

NEOVAULT® transforms the way organisations manage workplace testing and fatigue screening , replacing fragmented processes, manual paperwork, and disconnected records with a seamless end-to-end platform that empowers frontline teams to execute with confidence.

Whether managing one site or fifty, NEOVAULT® provides consistent, standardised testing across every location and shift, automated workflows that close the loop without chasing anyone down, audit-ready records that are always accurate and always accessible, and real-time oversight that gives leaders the visibility they need to act decisively.

Impairment
Testing

Neopharma Technologies has partnered with Impairment Science, Inc. to deliver the first integrated solution combining drug and alcohol testing with scientifically validated cognitive impairment screening — giving employers an objective, evidence-based foundation for workforce fitness-for-duty decisions.

Impairment Testing Screens

This is why NEOVAULT® is the future of digital
drug and impairment testing!

Badge 1
Badge 2
Badge 3
Badge 4

NEOVAULT® meets the highest international standards for data security and privacy — holding certifications across EU compliance, ISO 27001, HIPAA, and SOC 2 Type 2. For organisations operating across borders or under strict regulatory obligations, that's not just reassuring. It's essential.

Dual Advantage Image

Dual Advantage

Cannabis legalisation has created a genuine compliance challenge: traditional drug tests detect past use, not present impairment. NEOVAULT® solves this by combining drug and alcohol testing with cognitive impairment screening — giving employers an objective, defensible basis for fitness-for-duty decisions.
With NEOVAULT®, you can protect good employees who are not actually impaired, make clear and consistent decisions on THC results, and reduce testing costs with one integrated, device-agnostic platform.

Benefits
  • Real-time AI result interpretation — Eliminate guesswork at the point of collection. NEOVAULT® reads and interprets results instantly, reducing reliance on manual judgement and keeping your process moving.
  • Automated chain of custody — Every step is captured, timestamped, and locked. From collection through to reporting, your chain of custody is built automatically — no paperwork, no gaps.
  • Instant donor verification and ID capture — Confirm donor identity in seconds with built-in ID verification, giving your collectors confidence and your records integrity from the very first step.
  • End-to-end audit-ready records — Every test, result, and action is stored securely and retrievable on demand. When an audit comes, you're ready — without the scramble.
  • Single dashboard, multi-site visibility — Whether you're managing one site or fifty, NEOVAULT® gives leaders a live, consolidated view of testing activity across the entire organisation.
  • Seamless platform integrations — NEOVAULT® connects with the safety and workforce platforms you already use, so your teams work in one ecosystem — not across disconnected tools.
  • Guided collector workflows — Step-by-step digital guidance keeps collectors on process every time, reducing errors, improving consistency, and building frontline confidence.

Emerging Trends

Modern workplaces demand more than pre-employment screening. NEOVAULT® supports ongoing, proactive safety management — before shift start, during breaks, or at any point where fitness for duty needs to be confirmed. With zero equipment investment and full smartphone compatibility, it's the only solution that tests for both drug and alcohol presence and measures actual cognitive impairment in a single workflow.

Emerging Trends Dashboard
NEOVAULT® is built on a strategic partnership between Neopharma Technologies and Impairment Science, Inc. — bringing together best-in-class drug and alcohol testing with scientifically validated cognitive impairment detection. Contact us to discover how this integrated approach can strengthen workplace safety and streamline your compliance program.
Neovault Logo
Druid Logo
Impairment Science Logo
Neopharma Logo
NucleusAusChainHealgenAgamworksMotionCurveImpairmenScience360° DiagnosticsGlobalriskNucleusAusChainHealgenAgamworksMotionCurveImpairmenScience360° DiagnosticsGlobalrisk
Neopharma Technologies
EU CompliantISO 27001HIPAA CompliantSOC2 Type 2
Contact

Aus: 1800 636 8378

US/Ca: 1844 636 8378

Locations

Perth, Australia

Kuala Lumpur, Malaysia

Utah, USA


© 2026 Neopharma Technologies. All Rights Reserved

Privacy Policy